Therapy Areas: Diabetes
Innovent Biologics reports primary and all key secondary endpoints met in mazdutide Phase 3 trial
20 November 2025 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX: 01801) announced on Wednesday that the Phase 3 clinical trial of mazdutide, a first-in-class dual glucagon (GCG)/gluc...
Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin
18 November 2025 - Clinical-stage biopharmaceutical company Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) on Monday announced results from its joint research with Virginia Commonwealth University (VCU) eva...
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
12 November 2025 - Adocia (Euronext Paris:ADOC), a clinical-stage biopharmaceutical company focused on diabetes and obesity treatments, on Wednesday announced the filing of a patent for its new long-a...
Renalytix publishes pivotal kidneyintelX.dkd data in Diabetes Care and showcases clinical utility at ASN Kidney Week
12 November 2025 - Precision medicine diagnostics company Renalytix plc (LSE: RENX) (OTCQB: RNLXY) announced on Wednesday the publication of a pivotal study on its FDA-approved and Medicare-reimbursed...
10XREVIV Launch Announced in Abu Dhabi Through Partnership Between 10X Health, REVIV Global and M42
6 November 2025 - 10X Health in the United States and REVIV Global in the United Kingdom have entered into a strategic partnership with Abu Dhabi–based global health leader M42 to launch 10XREVI...
Tandem Diabetes Care launches t:slim X2 insulin pump with Abbott FreeStyle Libre 3 Plus integration in the US
29 October 2025 - Tandem Diabetes Care Inc (NASDAQ: TNDM) announced on Wednesday that it has launched the t:slim X2 insulin pump integrated with Abbott's FreeStyle Libre 3 Plus continuous glucose...